Well-grown cells were treated with ox-LDL. Total protein extraction was performed via RIPA buffer (Pierce, Rockford, USA). Protein was segregated by SDS-PAGE after quantification, and then transferred onto a PVDF membrane (Millipore, Billerica, MA, USA). The blots were incubated with primary antibodies against tumor necrosis factor α (TNF-α) (1 : 200, Abcam, Cambridge, United Kingdom), cleaved caspase-3 (1 : 1000, Abcam), cleaved PARP (1 : 1000, Abcam), or GAPDH (1 : 2000, Abcam, UK), and then added with secondary antibody (1 : 5000, Abcam). Finally, the signal was detected via an ECL Plus Detection kit (Pierce).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.